单孔与多孔胸腔镜肺叶切除术后早期患者报告结局比较
本研究基于前瞻性纵向研究CN-PRO-Lung 1数据,比较单孔与多孔胸腔镜肺癌肺叶切除术后早期患者报告结局。纳入174例患者,单孔组102例(58.6%),多孔组72例(41.4%)。调整混杂因素后,单孔组术后6天住院期间疼痛、疲乏、便秘、咳嗽、气短和睡眠紊乱严重程度更低,行走和享受生活能力严重受损比例更少,但生活质量评分、手术时间、胸管留置时间、住院时间和早期并发症率无显著差异。
要点
- 单孔组术后6天内疼痛、疲乏、便秘、咳嗽、气短、睡眠紊乱更轻
- 单孔组行走和享受生活能力严重受损比例更低
- 两组生活质量评分、手术时间、胸管时间、住院时间及并发症率无差异
核心结论
- 单孔胸腔镜肺叶切除术后早期可能比多孔胸腔镜产生更少的严重症状和更好的功能状态。
研究设计与样本
- 基于前瞻性纵向研究CN-PRO-Lung 1数据的比较分析,纳入174例肺癌肺叶切除患者,单孔组102例(58.6%),多孔组72例(41.4%)。
- 采用广义估计方程模型比较两组症状严重程度、功能状态和生活质量。
主要发现
- 调整混杂因素后,单孔组术后6天住院期间疼痛(P=.02)、疲乏(P=.001)、便秘(P=.01)、咳嗽(P=.003)、气短(P<.001)和睡眠紊乱(P=.007)严重程度低于多孔组。
- 单孔组行走(P=.033)和享受生活能力(P=.027)严重受损的患者比例更少。
- 两组生活质量评分、手术时间、胸管留置时间、住院时间和早期并发症率(II级或以上)均无显著差异(所有P>.05)。
关键数值与推荐
- 症状严重程度和功能状态以MD Anderson症状量表-肺癌模块0-10分评分中具有临床意义的严重评分患者比例报告。
临床怎么用
- 对于肺癌肺叶切除患者,单孔胸腔镜可能改善术后早期患者报告的症状负担和功能状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Uniportal video-assisted thoracoscopic surgery (U-VATS) can achieve traditional clinical outcomes comparable to those of multiportal video-assisted thoracoscopic surgery (M-VATS). This study aimed to compare patient-reported outcomes between U-VATS and M-VATS for lung cancer lobectomy in the early postoperative period. METHODS: This comparative analysis used data from a longitudinal prospective study (Perioperative Symptom Study of Lung Cancer [CN-PRO-Lung 1]). Symptom severity, functional status, and quality of life were compared between groups using generalized estimation equation models. Symptom severity and functional status were reported as proportion of patients with clinically meaningful severe scores on 0- to 10-point scales assessed using the MD Anderson Symptom Inventory-Lung Cancer module. RESULTS: Of the 174 patients included, 102 (58.6%) underwent U-VATS lobectomy and 72 (41.4%) underwent M-VATS lobectomy. After adjusting for confounders, patients in the U-VATS group reported less severe pain (P = .02), fatigue (P = .001), constipation (P = .01), coughing (P = .003), shortness of breath (P < .001), and disturbed sleep (P = .007) during the 6-day postoperative hospitalization than did patients in the M-VATS group. Moreover, fewer patients reported severe impairment in walking (P = .033) or their capacity to enjoy life (P = .027) in the U-VATS group. Meanwhile, there were no significant between-group differences in the quality of life scores, operative time, chest tube duration, length of hospital stay, or early complication rate (grade II or higher) (all P > .05). CONCLUSIONS: U-VATS may produce fewer severe symptoms and better functional status than M-VATS for lung cancer lobectomy in the early postoperative period.
引用
- Dai W, Dai Z, Wei X, et al. Early Patient-Reported Outcomes After Uniportal vs Multiportal Thoracoscopic Lobectomy. Ann Thorac Surg. 2021. PMID: 34599909. doi:10.1016/j.athoracsur.2021.08.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。